Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ARS Pharmaceuticals, Inc.
Age
12–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1\. Is a male or female subject between the ages of 12 and 65 years, inclusive.
2\. Asthma that has been stable for at least four weeks prior to screening as defined by clinical history.
3\. Reversible bronchoconstriction.
4\. Has body weight more than 30 kilogram (kg) and body mass index between 18 and 34 kg/m², inclusive.
5\. Has no medical history of hypertension and cardiovascular disease in the last 10 years.
6\. At screening, has stable vital signs.
You may not be if
1\. History of clinically significant gastrointestinal, renal, hepatic, neurologic, hematologic, endocrine, oncologic, pulmonary, immunologic, psychiatric, or cardiovascular disease or any other condition.
2\. Patients receiving beta blocker.
3\. Has any clinically significant medical condition or physical exam finding as deemed inappropriate by the Investigator.
4\. Has abnormal cardiovascular exam at screening including any prior history of myocardial infarction or clinically significant abnormal electrocardiogram.
5\. Has mucosal inflammatory disorders.
6\. Has had significant traumatic injury, major surgery or open biopsy within 30 days prior to study screening.
Clareo Health | Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma
